-
Mashup Score: 9Advances in Brain and Spinal Cord Tumor Research - 2 year(s) ago
Learn what’s new in brain and spinal cord tumor research, including progress in diagnosis, targeted therapies and immunotherapies, and radiation response. Treatment of brain and spinal cord tumors in children and quality of life research is also discussed, along with selected NCI-supported programs.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Rare Brain & Spine Tumor Network - 2 year(s) ago
NCI-CONNECT Rare Brain and Spine Tumor Network connects patients, providers, and advocates to help people with rare brain and spine tumors get better care.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#NCICONNECT works to advance the understanding of rare adult central nervous system cancers by establishing and fostering patient-advocacy-provider partnerships to improve approaches to care and treatment. Learn more about the program. https://t.co/zIoFeZ8AeL #CNStumors #gbmday https://t.co/aOANZx2Nb5
-
-
Mashup Score: 0
The median duration of response was not reached at a median follow-up of 26 months.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Larotrectinib can produce rapid and durable responses in children with #NTRK fusion-positive central nervous system tumors, according to updated trial results. Presented at #ISPNO2022. https://t.co/Vi3D6CdYnc #CNSTumors
-
-
Mashup Score: 0Molecular Analysis Refines Diagnosis, Enables Personalized Treatment for Pediatric CNS Tumors - 2 year(s) ago
Of the patients who completed follow-up, 60% had a targeted therapy recommendation.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Molecular analysis can improve diagnostic accuracy and guide treatment decisions for pediatric patients with central nervous system tumors and other cancers, according to researchers. Presented at #ISPNO2022. https://t.co/cDBMMghz9N #CNSTumors #PediatricCancer
-
-
Mashup Score: 0
The median duration of response was not reached at a median follow-up of 26 months.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Larotrectinib can produce rapid and durable responses in children with #NTRK fusion-positive central nervous system tumors, according to updated trial results presented at #ISPNO2022. https://t.co/RcFZ3omsVf #CNSTumors
-
-
Mashup Score: 0Extending Our Reach: Expanding Enrollment in Brain Metastases and Primary Brain Tumor Clinical Trials - 2 year(s) ago
Despite the unmet need, clinical trial opportunities for primary and metastatic central nervous system cancers are limited and clinical trial enrollment is poor. Multiple stakeholders have launched efforts to improve the clinical trial landscape for patients with primary and metastatic central nervous system tumors, including work that promotes the inclusion of patients with brain tumors into…
Source: ASCO Educational BookCategories: Hem/Oncs, Latest HeadlinesTweet-
Patients w brain tumors can face numerous barriers to enrollment in #clinicaltrials. Learn more about these & approaches to minimizing them in this paper by Drs. Eudocia Lee, Ross Camidge & @GautamMehtaMD. https://t.co/PqqmirHXQL #ASCOEdBook #CNSTumors #ASCO22
-
-
Mashup Score: 4Extending Our Reach: Expanding Enrollment in Brain Metastases and Primary Brain Tumor Clinical Trials - 2 year(s) ago
Despite the unmet need, clinical trial opportunities for primary and metastatic central nervous system cancers are limited and clinical trial enrollment is poor. Multiple stakeholders have launched efforts to improve the clinical trial landscape for patients with primary and metastatic central nervous system tumors, including work that promotes the inclusion of patients with brain tumors into…
Source: ASCO Educational BookCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patients w/ brain tumors face barriers to enrollment in #clinicaltrials. Learn more + approaches to minimizing them in this paper by Drs. Eudocia Lee, Ross Camidge & @GautamMehtaMD. 🧠 https://t.co/oBT6Coqxdo #ASCOEdBook #CNStumors #btsm @CancerResrch https://t.co/l8sNM8lPb1
-
-
Mashup Score: 14Oral Cavity, Oropharyngeal, Hypopharyngeal, and Laryngeal Cancers Prevention (PDQ®)–Patient Version - 2 year(s) ago
Oral cavity, oropharyngeal, hypopharyngeal, and laryngeal cancers prevention approaches include avoiding or reducing risk factors like smoking, alcohol, and oral HPV infection. Learn more about prevention of these cancers and risk factors in this expert-reviewed summary.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Head and neck cancers include cancers in the larynx, throat, lips, mouth, nose, and salivary glands. Tobacco use, heavy alcohol use, and infection with human papillomavirus (HPV) increase the risk of head and neck cancers. https://t.co/ECFrYKckcc #OralCancerAwareness #CNSTumors https://t.co/DYqkZ5bBVW
-
-
Mashup Score: 1
The discovery of a new mass involving the brain or spine typically prompts referral to a neurosurgeon to consider biopsy or surgical resection. Intraoperative decision-making depends significantly …
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this review, the authors discuss the use of #ArtificialIntelligence and #machinelearning for automated histologic diagnosis of #CNStumors. https://t.co/UAvYM76GrD https://t.co/brmvNAbyZC
-
-
Mashup Score: 0Dural-based atypical teratoid/rhabdoid tumor in an adult: DNA methylation profiling as a tool for the diagnosis | CNS Oncology - 4 year(s) ago
Atypical teratoid/rhabdoid tumor (ATRT) is a malignant CNS embryonal tumor that mostly occurs in childhood, adult cases are rare. We report a case of a 23-year-old male with an extra-axial dura-bas…
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This #casereport presents the case of a 23-year-old male with an extra-axial dura-based lesion in the left frontal area, previously diagnosed as #gliosarcoma, suggesting the usefulness of #DNAmethylation profiling for diagnosing challenging #CNStumors. https://t.co/BJUt6G5Cyy https://t.co/URsz1y06LN
-
Did you know 🤔? Tumors that begin in the brain 🧠 or spinal cord make up less than 2% of all cancers diagnosed each year in the U.S. And there are over 130 different types! So, what are the latest advances in #CancerResearch 🔬 for #CNSTumors? https://t.co/S0YoZ9eo9v https://t.co/SAfPyLBTLu